EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Are Putative Beta-Lactamases Posing a Potential Future Threat?

Patrik Mlynarcik iD, Veronika Zdarska iD, Milan Kolar iD

Antibiotics · 20.11.2025 · 14 (11) · 1174

DOI: 10.3390/antibiotics14111174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 20.11.2025. Verfasst von Patrik Mlynarcik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 77515 Olomouc, Czech Republic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Youth and Sports of the Czech Republic (MŠMT), Palacký University Olomouc, National Institute of Virology and Bacteriology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antimicrobial resistance is a growing global health threat, with beta-lactamases playing a central role in resistance to beta-lactam antibiotics. Building on our previous survey of 2340 putative beta-lactamases, we conducted an in-depth analysis of 129 prioritized candidates (70–98.5% amino acid identity to characterized enzymes) detected in 102 bacterial genera across 13 phylogenetic classes from environmental, animal, and human sources worldwide.

Methods

We applied a motif-centric assessment of class-defining catalytic residues, evaluated the genomic context using a heuristic Index of Proximal Mobility (IPM) derived from the two immediately adjacent open reading frames, and examined the phylogenetic placement. AI-based substrate predictions were generated at a restricted scope as exploratory evidence.

Results

Candidates spanned all Ambler classes (A–D); preservation of catalytic motifs was common and consistent with potential catalytic activity. Twelve of 129 (9.3%) loci had nearby mobile-element types (e.g., insertion sequences, integrases, transposases) and scored High IPM, indicating genomic contexts compatible with horizontal gene transfer. We also observed near-identical class A enzymes across multiple genera and continents, frequently adjacent to mobilization proteins.

Conclusions

We propose a reproducible, bias-aware, early warning framework that prioritizes candidates based on motif integrity and mobility context. The framework complements existing surveillance (GLASS/EARS-Net) and aligns with a One Health approach integrating human, animal, and environmental reservoirs. Identity thresholds and IPM are used for inclusion and contextual prioritization, rather than as proof of function or mobility; AI-based predictions serve as hypothesis-generating tools. Experimental studies will be essential to confirm enzymatic activity, mobility, and clinical relevance.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial resistancebeta-lactamaseshorizontal gene transferpublic health

Autor:innen und Institutionen

  • Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 77515 Olomouc, Czech Republic.

ORCID-Profile: Patrik Mlynarcik, Veronika Zdarska, Milan Kolar

Förderung

  • Ministry of Education, Youth and Sports of the Czech Republic (MŠMT)
  • Palacký University Olomouc
  • National Institute of Virology and Bacteriology
  • European Union—Next Generation EU

Zitieren

APA

Mlynarcik, P., Zdarska, V., & Kolar, M. (2025). Are Putative Beta-Lactamases Posing a Potential Future Threat?. Antibiotics, 14(11), 1174. https://doi.org/10.3390/antibiotics14111174

Vancouver

Mlynarcik P, Zdarska V, Kolar M. Are Putative Beta-Lactamases Posing a Potential Future Threat?. Antibiotics. 2025;14(11):1174. doi:10.3390/antibiotics14111174

BibTeX
@article{Mlynarcik2025,
  author = {Mlynarcik, Patrik and Zdarska, Veronika and Kolar, Milan},
  title = {Are Putative Beta-Lactamases Posing a Potential Future Threat?},
  journal = {Antibiotics},
  year = {2025},
  volume = {14},
  number = {11},
  pages = {1174},
  doi = {10.3390/antibiotics14111174}
}
Kostenlos starten →